New scan may reveal if brain cancer treatment is working sooner
NCT ID NCT06855628
Summary
This study aims to see if a new type of brain scan (called DMI) can predict how well a treatment works for glioblastoma, an aggressive brain cancer. It will test the scan in patients who are also receiving an experimental drug (BPM31510) added to standard care. The main goal is to see if the scan results can forecast how long patients live without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Stanford University
Palo Alto, California, 94305, United States
Conditions
Explore the condition pages connected to this study.